The clinical research study process begins with study assessment. During this stage, both the site and the study sponsor assess whether the site has the capabilities and resources necessary to successfully conduct the study.
After the confidential disclosure agreement is signed, the site can review the protocol to assess accrual feasibility and consider study logistics.
The investigator and other study personnel may be required to complete financial and/or conflict of interest disclosures prior to being formally selected as a study site by the sponsor. Once UMMC is selected as a site, the study team should finalize a recruitment plan and the informed consent form, taking into consideration UMMC's local context requirements.
Use the left-hand navigation pane to learn more about each step in the study assessment process.